Atom Investors LP Cti Biopharma Corp Transaction History

Atom Investors LP

  • $906 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022
SELL
$5.36 - $7.43 $369,722 - $512,506
-68,978 Reduced 52.06%
63,512 $370,000
Q2 2022

Aug 15, 2022
SELL
$3.55 - $6.27 $196,307 - $346,718
-55,298 Reduced 29.45%
132,490 $791,000
Q1 2022

May 16, 2022
BUY
$1.9 - $5.23 $139,988 - $385,335
73,678 Added 64.57%
187,788 $877,000
Q4 2021

Feb 14, 2022
BUY
$1.44 - $2.86 $164,318 - $326,354
114,110 New
114,110 $283,000

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email